相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combined Methods (Formal Adjusted Indirect Comparison, Meta-Analysis and Principal Component Analysis) Comparisons of the Safety and Efficacy of Ambrisentan, Bosentan, and Sildenafil in the Patients With Pulmonary Arterial Hypertension
Xinmei Li et al.
FRONTIERS IN PHARMACOLOGY (2020)
Predictors of operability in children with severe pulmonary hypertension associated with congenital heart disease
Shi-Bing Xi et al.
CHINESE MEDICAL JOURNAL (2019)
Metabolic map of osthole and its effect on lipids
Qi Zhao et al.
XENOBIOTICA (2018)
The prevalence of pulmonary arterial hypertension before and after atrial septal defect closure at adult age: A systematic review
Roxanne D. Zwijnenburg et al.
AMERICAN HEART JOURNAL (2018)
Treat-and-repair strategy is a feasible therapeutic choice in adult patients with severe pulmonary arterial hypertension associated with a ventricular septal defect: case series
Satoshi Akagi et al.
EUROPEAN HEART JOURNAL-CASE REPORTS (2018)
Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension
Carmine Dario Vizza et al.
BMC PULMONARY MEDICINE (2017)
Sildenafil for pulmonary hypertension in neonates
Lauren E. Kelly et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial
Robin H. Steinhorn et al.
JOURNAL OF PEDIATRICS (2016)
Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants
Kiran More et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Perioperative sildenafil therapy for pulmonary hypertension in infants undergoing congenital cardiac defect closure
Ashraf A. H. El Midany et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2013)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension
Robyn J. Barst et al.
CIRCULATION (2012)
A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn
W. A. Mohamed et al.
JOURNAL OF PERINATOLOGY (2012)
Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis
Spencer J. Melby et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)
A Comparison of Magnesium Sulphate and Sildenafil in the Treatment of the Newborns with Persistent Pulmonary Hypertension: A Randomized Controlled Trial
Sinan Uslu et al.
JOURNAL OF TROPICAL PEDIATRICS (2011)
Pulmonary Hypertension Related to Left-Sided Cardiac Pathology
Todd L. Kiefer et al.
PULMONARY MEDICINE (2011)
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association
Vallerie V. McLaughlin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: A pilot randomized blinded study
H Baquero et al.
PEDIATRICS (2006)
Initial experience with bosentan (Tracleer®) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children
N Gilbert et al.
ZEITSCHRIFT FUR KARDIOLOGIE (2005)
分享论文
